HomeTLT • CVE
add
Theralase Technologies Inc
Previous close
$0.20
Day range
$0.19 - $0.20
Year range
$0.14 - $0.38
Market cap
46.24M CAD
Avg Volume
131.98K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
In the news
Financials
Income Statement
Revenue
Net income
(CAD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 410.45K | 12.88% |
Operating expense | 1.19M | -2.58% |
Net income | -918.12K | 7.36% |
Net profit margin | -223.69 | 17.93% |
Earnings per share | — | — |
EBITDA | -880.61K | 7.57% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 268.76K | 512.05% |
Total assets | 3.25M | -0.91% |
Total liabilities | 1.18M | -13.99% |
Total equity | 2.07M | — |
Shares outstanding | 248.81M | — |
Price to book | 19.50 | — |
Return on assets | -71.54% | — |
Return on capital | -96.06% | — |
Cash Flow
Net change in cash
(CAD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -918.12K | 7.36% |
Cash from operations | -457.36K | 63.32% |
Cash from investing | -6.92K | 39.50% |
Cash from financing | 403.53K | -62.19% |
Net change in cash | -60.75K | 68.21% |
Free cash flow | -206.48K | 74.60% |
About
Founded
1989
Headquarters
Website
Employees
20